Chelsea Hopkins

Chelsea Hopkins serves as a Postdoc and Guest Researcher in the Department of Drug Design and Pharmacology at the University of Copenhagen, specializing in translational and clinical pharmacology. She is actively involved in The Graduate Programme for In Vivo Pharmacology and Experimental Animals, conducting research on rare skeletal disorders and pain mechanisms.

Her primary research focuses on fibrous dysplasia and McCune-Albright syndrome, with emphasis on disease pathogenesis, nociceptive pain pathways, and preclinical model development. She employs in vivo pharmacology techniques to investigate skeletal pain mechanisms and evaluate novel therapeutic interventions for rare bone diseases, bridging basic science and clinical applications.

Analysis of her 2022-2025 publications reveals a concentrated trajectory in fibrous dysplasia research, evolving from systematic model reviews to mechanistic pain studies and therapeutic development. Her work demonstrates increasing translational sophistication, moving from disease characterization to targeted pain management strategies using peripherally restricted compounds.

Dr. Hopkins maintains extensive international collaborations across North America and Europe, evidenced by co-authorship with leading researchers like Collins M.T. and Boyce A. Her participation in graduate training programs highlights her role in mentoring next-generation pharmacologists through The Graduate Programme for In Vivo Pharmacology and Experimental Animals.